Comparative Efficacy Of Consolidation Therapy After Chemoradiation Therapy (Crt) In Patients With Unresectable, Stage Iii Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

Posted on

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objectives: This study aims to estimate the comparative clinical efficacy of consolidation therapies after cCRT, by using network meta-analysis (NMA). This current analysis focuses on progression free survival (PFS). See poster 2018-ISPOR-AstraZeneca-Poster